DBV Technologies | DBVT - Beneficio Operativo





Beneficio Operativo Cambio Fecha
Acadia Pharmaceuticals USD 37.84M 42.45M 2026-06
Alnylam Pharmaceuticals USD 112.6M 24.99M 2026-06
Amarin USD -2.26M 564K 2025-12
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
BioMarin Pharmaceutical USD 105.6M 24.04M 2026-06
DBV Technologies USD -47.9M 2.85M 2026-03
Galectin Therapeutics USD -11.29M 1.64M 2024-06
Halozyme Therapeutics USD -63.72M 1.95M 2026-06
Incyte USD 700.4M 376.22M 2026-06
Insmed USD -101.31M 98.97M 2026-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Neurocrine Biosciences USD 219.9M 5.3M 2026-06
PTC Therapeutics USD 45.89M 127.51M 2026-03
Sarepta Therapeutics USD 13.29M 345.14M 2026-06
Ultragenyx Pharmaceutical USD -75M 141M 2026-06
United Therapeutics USD 330.8M 5M 2026-06